Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:07 PM
Ignite Modification Date:
2025-12-24 @ 10:07 PM
NCT ID:
NCT03420235
Eligibility Criteria:
Inclusion Criteria:
* All patients with a diagnosis of IPF according to the ATS 2011 criteria and about to start on anti-fibrotic treatment (either nintedanib or pirfenidone)
Exclusion Criteria:
* Not able to speak, read or write in Dutch
* No access to internet
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03420235
Study Brief:
Protocol Section:
NCT03420235